High antitumor activity of pladienolide B and its derivative in gastric cancer - Wikidata - wikimedia - TriplyDB

High antitumor activity of pladienolide B and its derivative in gastric cancer

High antitumor activity of pladienolide B and its derivative in gastric cancer

http://www.wikidata.org/entity/Q35051717

about

Microbial and Natural Metabolites That Inhibit Splicing: A Powerful Alternative for Cancer Treatment Splicing function of mitotic regulators links R-loop-mediated DNA damage to tumor cell killing Global analysis of pre-mRNA subcellular localization following splicing inhibition by spliceostatin A.Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy Functional Genomic Screening Reveals Splicing of the EWS-FLI1 Fusion Transcript as a Vulnerability in Ewing Sarcoma.Design and synthesis of analogues of natural products.Discoveries, target identifications, and biological applications of natural products that inhibit splicing factor 3B subunit 1.Flow cytometric analysis identifies changes in S and M phases as novel cell cycle alterations induced by the splicing inhibitor isoginkgetin.Alternative Splicing as a Target for Cancer Treatment.Enantioselective Synthesis of Spliceostatin G and Evaluation of Bioactivity of Spliceostatin G and Its Methyl Ester.CRISPR/Cas9-mediated target validation of the splicing inhibitor Pladienolide B.A Novel Theranostic Combination of Near-infrared Fluorescence Imaging and Laser Irradiation Targeting c-KIT for Gastrointestinal Stromal Tumors.Targeting the spliceosome for cutaneous squamous cell carcinoma therapy: a role for c-MYC and wild-type p53 in determining the degree of tumour selectivity.

P2860

Q28074931-DB26E680-E7EC-4764-A12E-EF849F4C7A66 Q35543181-BFE4F963-26C4-4DC9-869E-9275E0A0A270 Q36165982-B550C3E7-DBA1-4326-9C0A-C63A0EA0295C Q36447664-71B729C2-9A25-4EAD-B471-0B847151A310 Q36584775-D3ABD182-4629-44B6-A63B-80B81A889632 Q38398596-E9FC224F-30CE-432B-B8AF-E14040058B84 Q38712211-60C34123-FBE3-4D71-801B-936BFDE4A5BF Q48235204-D6055C08-DE91-41B3-AC37-66AEEA9869CA Q50033988-93E94A18-A242-4A89-99A5-09260A16C7DA Q50424397-E0803CBA-C715-47F1-AA41-868D169D8A2B Q52430362-CADE4CCE-9E64-4F4C-9617-91983CF4DB81 Q52714383-30F04467-084F-4235-A92C-5178B54D32C6 Q55137359-1959A5B7-5D83-46DC-B4BE-A821C2DB057B

P2860

High antitumor activity of pladienolide B and its derivative in gastric cancer

http://www.wikidata.org/entity/Q35051717

description

2013 nî lūn-bûn

@nan

2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

High antitumor activity of pladienolide B and its derivative in gastric cancer

@ast

High antitumor activity of pladienolide B and its derivative in gastric cancer

@en

type

label

High antitumor activity of pladienolide B and its derivative in gastric cancer

@ast

High antitumor activity of pladienolide B and its derivative in gastric cancer

@en

prefLabel

High antitumor activity of pladienolide B and its derivative in gastric cancer

@ast

High antitumor activity of pladienolide B and its derivative in gastric cancer

@en

P1433

Q35051717-C740BFDD-4605-4F54-8E46-90DC926B900E

P1476

Q35051717-89149183-FD18-40BA-9416-33806F2207B0

P2093

Q35051717-044A62CB-5C6D-4474-82D2-796C980FD7E1

Q35051717-19E653A5-FA8F-42DC-ACA3-0287F62E7253

Q35051717-1D494179-178D-4AC4-97F9-20499423D8C4

Q35051717-32192A3B-80E8-4276-BED9-9B05A05291AC

Q35051717-3C4D1402-2CF2-4C76-896B-74A3EBC7F855

Q35051717-5B526240-B2A6-4AB8-849A-98052E7DA43D

Q35051717-6507875F-DB2F-4A73-A05F-6A17D2F4E8D0

Q35051717-6AAE71E9-D9AA-4D3E-8C6D-B93EEDB214D9

Q35051717-874F3630-0A89-4068-929D-6FE82B3023A7

Q35051717-8A71E84B-21CE-4697-9654-66FDA68C07A5

P2860

Q35051717-10F8348B-3DC0-483C-8833-0DF1901D8218

Q35051717-213A2595-1E45-4787-967F-CC6A05CF47CE

Q35051717-26598A96-0882-4068-AC79-CB7C8FB1E9F7

Q35051717-3EB1E4B9-6230-4ED5-98C8-157B599360E8

Q35051717-555B4D17-B48A-4FEC-93EF-C139F5E78B40

Q35051717-6408E487-C7DE-45DF-BF55-3EA2AB8A351D

Q35051717-648E59E6-48A5-4A50-8489-C57FD53F9A04

Q35051717-6B918064-6040-407F-857A-C799C34DACFA

Q35051717-6E33735E-D558-4DA9-A5CD-21C31A9197E8

Q35051717-70A288B2-2CF8-4460-94EC-0C90D25423DB

P304

Q35051717-76239413-69DC-4C7D-B8F4-8DC97099F488

P31

Q35051717-D2208138-1DDF-4662-B05E-C66BD5F90AA9

P356

Q35051717-0F99D412-06B7-4588-BA71-BCBE61011B09

P433

Q35051717-0933BFE7-E9CF-44A2-A08C-A6FCF37FD2DB

P478

Q35051717-9147AAD2-9D68-4A35-87E3-A72FCE0C7C62

P50

Q35051717-43009F44-23E2-4FA8-B7A9-EA40BAF390EB

P577

Q35051717-366DEC68-5C87-42D3-A570-985397511344

P5875

Q35051717-1974EC53-5686-4ED0-BB39-FBBEE359DE2C

P698

Q35051717-C1C0100D-2589-4CF2-A46E-768F6E0D1F63

P932

Q35051717-FD5F1071-522F-4EAD-883C-54508EA5178A

P356

P1433

P1476

High antitumor activity of pladienolide B and its derivative in gastric cancer

@en

P2093

Hiroaki Mikasa

http://www.w3.org/2001/XMLSchema#string

Hiromi Yano

http://www.w3.org/2001/XMLSchema#string

Hiroshi Miyamoto

http://www.w3.org/2001/XMLSchema#string

Katsutaka Sannomiya

http://www.w3.org/2001/XMLSchema#string

Koichi Okamoto

http://www.w3.org/2001/XMLSchema#string

Masao Iwata

http://www.w3.org/2001/XMLSchema#string

Momoko Sato

http://www.w3.org/2001/XMLSchema#string

Satoshi Wada

http://www.w3.org/2001/XMLSchema#string

Shinji Kitamura

http://www.w3.org/2001/XMLSchema#string

Tadahiko Nakagawa

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Specific targeting of caspase-9/PP2A interaction as potential new anti-cancer therapy

Gastric cancer incidence and mortality in Zhuanghe, China, between 2005 and 2010.

Phase I study of S-1, docetaxel and cisplatin combination chemotherapy in patients with unresectable metastatic gastric cancer.

Splicing in oncogenesis and tumor suppression.

The spliceosome as a target of novel antitumour drugs.

Biological validation that SF3b is a target of the antitumor macrolide pladienolide.

P304

110-116

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/CAS.12317

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

260873827

http://www.w3.org/2001/XMLSchema#string

P698

24635824

http://www.w3.org/2001/XMLSchema#string

P932

4317874

http://www.w3.org/2001/XMLSchema#string